https://www.statnews.com/2020/08/17/unity-biotechnology-fails-an-early-test-raising-doubts-its-ability-to-develop-drugs-to-reverse-aging-symptoms/?utm_source=STAT+Newsletters&utm_campaign=06a0de771b-gw&utm_medium=email&utm_term=0_8cab1d7961-06a0de771b-149692869

STAT Plus: Unity Biotechnology fails early test, raising doubts its ability to develop drugs to reverse aging symptoms

By ADAM FEUERSTEIN

ADOBE

The outcome is likely to raise new doubts about the biotech’s ability to develop drugs to reverse the symptoms and diseases associated with aging.

READ MORE